Another study performed by Gupta et al., (2012) on 30 females recently diagnosed breast cancer patients and 100 healthy females as controls found a significantly lower SOD and GPx activity and lower serum TAC levels in breast cancer patients when compared to the control group. This evidence concerns the gene SOD1 and breast carcinoma.